Bernard Mach

Active 1973–2010

64
Papers
18,386
Citations
64
h-index
64
i10-index

Citations

Citations per year for Bernard Mach1973: 4 citations1974: 5 citations1975: 4 citations1976: 8 citations1977: 10 citations1978: 6 citations1979: 4 citations1980: 4 citations1981: 8 citations1982: 14 citations1983: 45 citations1984: 73 citations1985: 60 citations1986: 54 citations1987: 43 citations1988: 45 citations1989: 67 citations1990: 73 citations1991: 78 citations1992: 58 citations1993: 70 citations1994: 93 citations1995: 100 citations1996: 63 citations1997: 128 citations1998: 146 citations1999: 163 citations2000: 183 citations2001: 186 citations2002: 148 citations2003: 120 citations2004: 90 citations2005: 104 citations2006: 43 citations2007: 43 citations2008: 71 citations2009: 59 citations2010: 86 citations2011: 58 citations2012: 64 citations2013: 37 citations2014: 57 citations2015: 45 citations2016: 22 citations2017: 34 citations2018: 35 citations2019: 90 citations2020: 108 citations2021: 97 citations2022: 84 citations2023: 83 citations2024: 145 citations2025: 47 citations2026: 1 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,144 citing papers, 35.6% of this breakdownUnited Kingdom: 260 citing papers, 8.1% of this breakdownGermany: 212 citing papers, 6.6% of this breakdownFrance: 201 citing papers, 6.3% of this breakdownSwitzerland: 175 citing papers, 5.4% of this breakdownJapan: 116 citing papers, 3.6% of this breakdownCanada: 115 citing papers, 3.6% of this breakdownChina: 115 citing papers, 3.6% of this breakdownNetherlands: 106 citing papers, 3.3% of this breakdownItaly: 79 citing papers, 2.5% of this breakdownAustralia: 76 citing papers, 2.4% of this breakdownSweden: 70 citing papers, 2.2% of this breakdown
0%35.6%Other 16.8%

Fields

  • Immunology and Microbiology40.3%
  • Medicine27.3%
  • Biochemistry, Genetics and Molecular Biology26.3%
  • Agricultural and Biological Sciences2.7%
  • Neuroscience1.7%
  • Chemistry0.5%
  • Other1.2%

Topics

  • T-cell and B-cell Immunology10.9%
  • Immune Cell Function and Interaction10%
  • Immunotherapy and Immune Responses6.9%
  • Immune Response and Inflammation2.9%
  • Monoclonal and Polyclonal Antibodies Research2.4%
  • Diabetes and associated disorders1.7%
  • Other65.2%

Coauthors

All papers

Open in search
  1. Nomenclature for Factors of the HLA System, 2026

    Authors: , , , , , , , , , , , , , , - Tissue Antigens 2010 cited by 4,124

  2. Regulation of MHC Class II Expression by Interferon-γ Mediated by the Transactivator Gene CIITA

    Authors: , , , , - Science 1994 cited by 905

  3. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome)

    Authors: , , , - Cell 1993 cited by 842

  4. Activation of the MHC Class II Transactivator CIITA by Interferon-γ Requires Cooperative Interaction between Stat1 and USF-1

    Authors: , , , - Immunity 1998 cited by 375

  5. Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA

    Authors: , , , - The EMBO Journal 1997 cited by 503

  6. A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients

    Authors: , , , , , , , , , - Nature Genetics 1998 cited by 274

  7. The Bare Lymphocyte Syndrome and the Regulation of MHC Expression

    Authors: , - Annual Review of Immunology 2001 cited by 520

  8. REGULATION OF MHC CLASS II GENES: Lessons from a Disease

    Authors: , , , - Annual Review of Immunology 1996 cited by 490

  9. RFXAP, a novel subunit of the RFX DNA binding complex is mutated in MHC class II deficiency

    Authors: , , , , , , - The EMBO Journal 1997 cited by 224

  10. Developmental extinction of major histocompatibility complex class II gene expression in plasmocytes is mediated by silencing of the transactivator gene CIITA.

    Authors: , , , , - The Journal of Experimental Medicine 1994 cited by 158

  11. A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome).

    Authors: , , , , , , - Genes & Development 1995 cited by 339

  12. Structure of the winged-helix protein hRFX1 reveals a new mode of DNA binding

    Authors: , , , , , , - Nature 2000 cited by 322

  13. A Human Endogenous Retroviral Superantigen as Candidate Autoimmune Gene in Type I Diabetes

    Authors: , , , , , - Cell 1997 cited by 405

  14. Congenital immunodeficiency with a regulatory defect in MHC class II gene expression lacks a specific HLA-DR promoter binding protein, RF-X

    Authors: , , , , , , , - Cell 1988 cited by 267

  15. RFX Proteins, a Novel Family of DNA Binding Proteins Conserved in the Eukaryotic Kingdom

    Authors: , , , - Nucleic Acids Research 1996 cited by 204

  16. Nomenclature for factors of the HLA system, 1998

    Authors: , , , , , , , , , , , , , , , , - Tissue Antigens 1999 cited by 263

  17. Nomenclature for factors of the HLA system, 2002

    Authors: , , , , , , , , , , , , , , , - Tissue Antigens 2002 cited by 186

  18. Function of major histocompatibility complex class II promoters requires cooperative binding between factors RFX and NF-Y.

    Authors: , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 1994 cited by 176

  19. MHC class II regulatory factor RFX has a novel DNA-binding domain and a functionally independent dimerization domain.

    Authors: , , , , , , , - Genes & Development 1990 cited by 173

  20. Alternative splicing and alternative initiation of translation explain the four forms of the Ia antigen‐associated invariant chain.

    Authors: , , - The EMBO Journal 1986 cited by 162

  21. Nomenclature for factors of the HLA system, 1989

    Authors: , , , , , , , , , , , , , - Tissue Antigens 1990 cited by 131

  22. Quantitative control of MHC class II expression by the transactivator CIITA

    Authors: , , , - European Journal of Immunology 1998 cited by 119

  23. Nomenclature for factors of the HLA system, 1991

    Authors: , , , , , , , , , , , , , - Tissue Antigens 1992 cited by 339

  24. The complete sequence of the mRNA for the HLA‐DR‐associated invariant chain reveals a polypeptide with an unusual transmembrane polarity.

    Authors: , , - The EMBO Journal 1984 cited by 121